Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ned Powell

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Journal of Medical Virology|June 6, 2014
mRNA sequencing of novel cell lines from human papillomavirus type-16 related vulval intraepithelial neoplasia: consequences of expression of HPV16 E4 and E5Dean Bryant, Tiffany Onions, Rachel Raybould, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 21, 2013
Cervical cancers associated with human papillomavirus types 16, 18 and 45 are diagnosed in younger women than cancers associated with other types: a cross-sectional observational study in Wales and Scotland (UK)Ned Powell, Kate Cuschieri, Heather Cubie, et al.
International Journal of Cancer|January 22, 2013
HPV16 L1 and L2 DNA methylation predicts high-grade cervical intraepithelial neoplasia in women with mildly abnormal cervical cytologyAttila T Lorincz, Adam R Brentnall, Nataša Vasiljević, et al.
Journal of Clinical Pathology|November 21, 2014
Type-specific HPV prevalence in invasive cervical cancer in the UK prior to national HPV immunisation programme: baseline for monitoring the effects of immunisationDavid Mesher, Kate Cuschieri, Sam Hibbitts, et al.
The Lancet. Oncology|October 12, 2014
Activity, safety, and feasibility of cidofovir and imiquimod for treatment of vulval intraepithelial neoplasia (RT³VIN): a multicentre, open-label, randomised, phase 2 trialAmanda Tristram, Christopher N Hurt, Tracie Madden, et al.
BMC Cancer|August 28, 2015
PATHOS: a phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV) positive oropharyngeal cancerWaheeda Owadally, Chris Hurt, Hayley Timmins, et al.
Head & Neck|January 11, 2016
Geographic variation in human papillomavirus-related oropharyngeal cancer: Data from 4 multinational randomized trialsHisham Mehanna, Natalie Franklin, Natalie Compton, et al.
The New England Journal of Medicine|March 24, 2016
PET-CT Surveillance versus Neck Dissection in Advanced Head and Neck CancerHisham Mehanna, Wai-Lup Wong, Christopher C McConkey, et al.
International Journal of Cancer|July 4, 2012
Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in EuropeWiebren A Tjalma, Alison Fiander, Olaf Reich, et al.
International Journal of Cancer|June 23, 2015
Human papillomavirus prevalence and type-distribution in cervical glandular neoplasias: Results from a European multinational epidemiological studyKatsiaryna Holl, Andrzej M Nowakowski, Ned Powell, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Journal of Medical Virology|June 6, 2014
mRNA sequencing of novel cell lines from human papillomavirus type-16 related vulval intraepithelial neoplasia: consequences of expression of HPV16 E4 and E5Dean Bryant, Tiffany Onions, Rachel Raybould, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 21, 2013
Cervical cancers associated with human papillomavirus types 16, 18 and 45 are diagnosed in younger women than cancers associated with other types: a cross-sectional observational study in Wales and Scotland (UK)Ned Powell, Kate Cuschieri, Heather Cubie, et al.
International Journal of Cancer|January 22, 2013
HPV16 L1 and L2 DNA methylation predicts high-grade cervical intraepithelial neoplasia in women with mildly abnormal cervical cytologyAttila T Lorincz, Adam R Brentnall, Nataša Vasiljević, et al.
Journal of Clinical Pathology|November 21, 2014
Type-specific HPV prevalence in invasive cervical cancer in the UK prior to national HPV immunisation programme: baseline for monitoring the effects of immunisationDavid Mesher, Kate Cuschieri, Sam Hibbitts, et al.
The Lancet. Oncology|October 12, 2014
Activity, safety, and feasibility of cidofovir and imiquimod for treatment of vulval intraepithelial neoplasia (RT³VIN): a multicentre, open-label, randomised, phase 2 trialAmanda Tristram, Christopher N Hurt, Tracie Madden, et al.
BMC Cancer|August 28, 2015
PATHOS: a phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV) positive oropharyngeal cancerWaheeda Owadally, Chris Hurt, Hayley Timmins, et al.
Head & Neck|January 11, 2016
Geographic variation in human papillomavirus-related oropharyngeal cancer: Data from 4 multinational randomized trialsHisham Mehanna, Natalie Franklin, Natalie Compton, et al.
The New England Journal of Medicine|March 24, 2016
PET-CT Surveillance versus Neck Dissection in Advanced Head and Neck CancerHisham Mehanna, Wai-Lup Wong, Christopher C McConkey, et al.
International Journal of Cancer|July 4, 2012
Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in EuropeWiebren A Tjalma, Alison Fiander, Olaf Reich, et al.
International Journal of Cancer|June 23, 2015
Human papillomavirus prevalence and type-distribution in cervical glandular neoplasias: Results from a European multinational epidemiological studyKatsiaryna Holl, Andrzej M Nowakowski, Ned Powell, et al.
Pageof 3